Lung Cancer

Cardiovascular disease, especially atherosclerotic CVD, was associated with increased risk for cancer diagnosis, according to a study published in JACC: CardioOncology.

Researchers have begun enrolling patients in Pragmatica-Lung, an NCI-supported phase 3 study designed specifically to eliminate barriers to clinical trial accessibility and participation.

High incidence of lung cancer paired with stable lung cancer-related mortality rates when low-dose CT screening was introduced suggests overdiagnosis, specifically in women, according to study results published in CHEST.

Healio compiled the most-read news in pulmonology posted in March.

Osimertinib extended DFS and reduced risk for recurrence among patients with resected EGFR-mutated non-small cell lung cancer, according to an updated analysis of data from the phase 3 ADAURA trial published in Journal of Clinical Oncology.

Neoadjuvant nivolumab plus platinum-based chemotherapy conferred sustained clinical benefit for patients with resectable non-small cell lung cancer, 3-year follow-up results of the phase 3 CheckMate -816 trial showed.

Overall treatment outcomes among patients with extensive-stage small cell lung cancer who received first-line chemoimmunotherapy appeared comparable to those reported in pivotal clinical trials, according to study results.

Patients with limited-stage small cell lung cancer who received higher-dose, once-daily radiotherapy achieved outcomes comparable to those who received the standard lower-dose, once-daily regimen, according to phase 3 study results.

In a cohort of smokers screened for lung cancer, women, unmarried individuals, African Americans and those with a low education level had a low likelihood of attempting to quit smoking, according to study results published in CHEST.

Moderate to severe depression in patients with lung cancer was linked to elevated inflammation levels, and the biomarkers measuring inflammation predicted poor survival, according to study results published in PLOS ONE.